Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The new compound may be a safer alternative to finasteride for prostate protection.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Finasteride may increase the risk of suicidality and depression, especially in younger people.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Zinc sulphate may help reduce skin damage from radiation therapy.

The combination of tretinoin, minoxidil, and betamethasone valerate may cause severe scalp inflammation.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Retinoic acid can either maintain stem cells or make them specialize, depending on the cell type.

A girl had rickets due to a gene mutation affecting vitamin D response.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Wedelolactone may help reduce bone loss with fewer side effects.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

New treatments are making advanced prostate cancer management more complex but also more hopeful.